Cipher Capital’s Bristol-Myers Squibb BMY Stock Holding History

Cipher Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$370K	Sell	6,827 -12,484	-65%	-$636K	0.17%	220
2023 Q4	$991K	Buy	19,311 +13,315	+222%	+$699K	0.32%	82
2023 Q3	$348K	Buy	+5,996	New	+$367K	0.25%	148

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cipher Capital's BMY Position: Q1 2024 in Review

Cipher Capital reduced its Bristol-Myers Squibb (BMY) stake by 65% in Q1 2024, selling an estimated $636K and leaving 6,827 shares worth $370K. The position accounts for 0.17% of the portfolio, ranked #220.

Cipher Capital first reported a position in BMY in Q3 2023 and has held it in 3 quarters since. The position peaked at $991K in Q4 2023. 2,331 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

Cipher Capital held 6,827 shares of Bristol-Myers Squibb worth $370K as of Q1 2024.
Cipher Capital sold 12,484 Bristol-Myers Squibb shares in Q1 2024, an estimated $636K.
Bristol-Myers Squibb made up 0.17% of Cipher Capital's portfolio in Q1 2024, its #220 holding.
Cipher Capital first reported a position in Bristol-Myers Squibb in Q3 2023 and has held it in 3 quarters since.
Cipher Capital's Bristol-Myers Squibb position peaked at $991K in Q4 2023.
2,331 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on Cipher Capital's 13F filing for Q1 2024, filed 15 May 2024.